Icenhour Presentation Wednesday, January 24, 8:00 a.m PST at the Computer Museum in Mountain View, CA
Ashburn, VA –, January 19, 2017 – Dr. Crystal Icenhour, an expert in infectious disease diagnostics and a speaker at the upcoming Precision Medicine World Conference will present to attendees how Aperiomics is leading the industry in identifying, for the first time, infectious disease using deep shotgun metagenomic sequencing. Aperiomics is the only company in the world providing this service to healthcare providers.
Her presentation is Wednesday, January 24 at 8 a.m. PST, at the Computer Museum in Mountain View, CA.
Today, up to 75% of infections are never accurately diagnosed, wasting time and millions of dollars spent in trial-and-error testing and treatment. Icenhour and her team have cut weeks, months and even years off of the time in which patients suffer from infectious diseases. The company identifies every known pathogen (bacteria, virus, fungi and parasite) in a single test through a process called deep shotgun metagenomic sequencing of DNA from any sample (patient, environmental, etc.). It takes one to two weeks to get results.
Icenhour holds two patents, has authored numerous research articles and is a prolific speaker at scientific conferences. She has served on review panels for the NSF, the EPA and NIH. She is an adjunct professor of medicine at Duke University Medical Center. Dr. Icenhour received her PhD in Pathobiology and Molecular Medicine from the University of Cincinnati Medical School. She trained as a postdoctoral fellow in the Thoracic Diseases Research Unit at the Mayo Clinic, as well as in the Infectious Disease Department at Duke University Medical Center. Additionally, she is well-versed in entrepreneurship, biotechnology business and politics, and women in business. She was featured recently in an article in Inc. Magazine. Editors who would like to meet with Dr. Icenhour at the event can contact Robert Deigh at email@example.com or 703-401-6339.
Aperiomics is the only company identifying every bacteria, DNA virus, fungi and parasite in one test. Clinicians and patients call on Aperiomics to identify infectious diseases that other tests cannot identify. The only company of its kind and scope in the world, Aperiomics identifies every known pathogen (bacteria, virus, fungi or parasite) in a single test through deep shotgun metagenomic sequencing of the DNA in any sample (patient, environmental, etc.). The complete genetic fingerprint of that sample is then compared to the Aperiomics Microbial Database™- the most comprehensive database of microorganisms, including the world’s largest collection of pathogens. This breakthrough is only possible through Aperiomics and can be used to identify unknown/chronic infections, limit the use of antibiotics and solve difficult medical cases. Patients and their families often contact Aperiomics directly after hearing about our successes in helping others. Aperiomics is supported by the National Science Foundation and was named Life Sciences Innovators of the Year in 2016 and a finalist in the 2017 Greater Washington Innovation Awards. For more information, visit www.aperiomics.com or call (703) 229-0406.